Respira Therapeutics

company

About

Respiras high efficiency AOS Dry Powder Inhaler (DPI) technologies deliver dry powder drug products to the lung more effectively.

  • Albuquerque,New Mexico,United States
  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$2M
Industries
Health Care,Medical,Therapeutics
Founded date
Jan 1, 2010
Number Of Employee
1 - 10
Operating Status
Active

Respira is a product development-stage company focused on pulmonary delivery of therapeutics for respiratory diseases with unmet medical needs. The company realized seed capitalization from the Cottonwood Technology Fund on October 2010 for scientific development and commercialization of its patent pending technology for passive dry powder inhalers (DPI), consisting of a unique drug delivery engine with a novel, patent pending mechanism of action for lung delivery and therapy. Clinical proof-of-principle has been achieved. Respira Therapeutics DPIs have demonstrated "best-in-class" drug dispersion performance, and are uniquely positioned to replace currently marketed devices and to broaden inhaled therapies to drug classes/disease indications in high value therapeutic areas by virtue of superior performance and payload outcomes.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
5
$5.10M
Respira Therapeutics has raised a total of $5.10M in funding over 2 rounds. Their latest funding was raised on Nov 1, 2015 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 1, 2015 Series B 1 Detail
Jan 30, 2015 Convertable Note $600K 2 Sun Mountain Capital Detail
Oct 1, 2014 Convertable Note $1.50M 2 Sun Mountain Capital Detail
Aug 13, 2013 Series A $2M 2 Sun Mountain Capital Detail
Oct 1, 2010 Series A $1M 1 Detail

Investors

Number of Lead Investors
Number of Investors
3
3
Respira Therapeutics is funded by 3 investors. Sun Mountain Capital and Keiretsu Forum Northwest are the most recent investors.
Investor Name Lead Investor Funding Round
Sun Mountain Capital Yes Convertable Note
Keiretsu Forum Northwest Series B
Cottonwood Technology Fund Convertable Note

Employee Profiles

Number of Employee Profiles
7
Respira Therapeutics has 7 current employee profiles, including Executive David Blivin
Executive
Board member
Executive
Executive
Executive